Consulting in translational neuroscience research; providing key expertise in the areas of neurological developmental disorders, psychiatry, and circadian rhythms; scientific consulting on flowcharts and in-vivo pharmacology study design for target engagement, mechanism-based models, pharmacokinetic-pharmacodynamic relationships, and proof-of-concept studies; evaluation of preclinical data packages supporting entry into human medicine; identification of strategic business partners from academia, industry, and contract research, and facilitation of collaborations. The company may establish branches in Switzerland and abroad, participate in other companies in Switzerland and abroad, acquire or merge with similar or related companies, and enter into any business and conclude any contracts that are suitable to promote the purpose of the company or are directly or indirectly related to it. It may acquire, manage, encumber, and dispose of real estate, intellectual property rights, and licenses of all kinds.